Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

AbbVie Completes Acquisition of Pharmacyclics
Yahoo
Tue, 05/26/15 - 09:43 am
Tags:
AbbVie, Pharmacyclics, M&A
Who are Gilead Sciences' (GILD) main competitors?
Investopedia
Fri, 05/22/15 - 10:56 am
Tags:
Gilead Sciences, GSK, Pfizer, AbbVie, Merck, Bristol-Myers Squibb
Abbvie specifies breakdown of $21 billion Pharmacyclics deal
Yahoo/AP
Thu, 05/21/15 - 12:43 pm
Tags:
AbbVie, Pharmacyclics, M&A
AbbVie, other pharma companies dominate list of 'most meaningful' places to work in US
BioPharma Dive
Thu, 05/21/15 - 12:40 pm
Tags:
AbbVie, Becton Dickinson, Celgene, Medtronic
The top 10 advertisers in Big Pharma
Fierce Pharma Marketing
Mon, 05/18/15 - 11:27 am
Tags:
Pfizer, AbbVie, AstraZeneca, Eli Lilly, JNJ, Actavis, Merck, Bristol-Myers Squibb, Dainippon Sumitomo, Amgen, drug ads
AbbVie nabs FDA's orphan drug tag for Humira in HS
Fierce Pharma
Sun, 05/17/15 - 01:46 pm
Tags:
AbbVie, FDA, Humira, orphan drugs, hidradenitis suppurativa
AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc.
Yahoo
Sat, 05/16/15 - 02:10 pm
Tags:
AbbVie, Pharmacyclics, M&A
Galapagos inflates IPO again as AbbVie, J&J jockey for position
Fierce Biotech
Thu, 05/14/15 - 11:02 am
Tags:
Galapagos, IPOs, AbbVie, JNJ
Bristol, AbbVie drug extends multiple myeloma remission-study
Yahoo/Reuters
Thu, 05/14/15 - 09:56 am
Tags:
Bristol-Myers Squibb, AbbVie, Multiple Myeloma, elotuzumab
Pharmacyclics-AbbVie Merger Has Many Moving Parts
Seeking Alpha
Wed, 05/13/15 - 11:21 am
Tags:
AbbVie, Pharmacyclics, M&A
AbbVie, Roche nab FDA breakthrough designation for top leukemia prospect
BioPharma Dive
Fri, 05/8/15 - 11:01 am
Tags:
AbbVie, Roche, FDA, CLL, chronic lymphocytic leukemia, venetoclax
AbbVie leukemia drug gets breakthrough status
Medical Marketing and Media
Wed, 05/6/15 - 06:59 pm
Tags:
AbbVie, CLL, chronic lymphocytic leukemia, venetoclax
The Q1 drug launch scorecard, starring Sanofi, Lilly, Pfizer, Gilead, Merck and more
Fierce Pharma Marketing
Mon, 05/4/15 - 04:43 pm
Tags:
earnings, Sanofi, Eli Lilly, Pfizer, Gilead Sciences, Merck, AbbVie
AbbVie Again Extends Exchange Offer to Acquire Pharmacyclics, Inc.
Marketwatch
Sat, 05/2/15 - 01:14 pm
Tags:
AbbVie, Pharmacyclics, M&A
AbbVie Pushing Hepatitis C Pipeline, But Is It Fast Enough?
Seeking Alpha
Wed, 04/29/15 - 09:57 am
Tags:
AbbVie, hepatitis C, Viekira Pak, Japan, Europe
Gilead Will Keep Hepatitis C Dominance In Its Grip With Recent Trial Results
Seeking Alpha
Tue, 04/28/15 - 08:49 am
Tags:
Gilead Sciences, Harvoni, hepatitis C, AbbVie, Bristol-Myers Squibb, Merck, Achillion
Roche, Amgen, Novo top the ranks in biologics sales, with AbbVie, Sanofi close behind
Fierce Pharma
Mon, 04/27/15 - 09:12 pm
Tags:
Roche, Amgen, Novo Nordisk, AbbVie, Sanofi
FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C
Marketwatch
Fri, 04/24/15 - 10:55 am
Tags:
FDA, AbbVie, OBV/PTV/r, Chronic Hepatitis C
Stellar Humira sales underscore AbbVie's need for replacement meds
Fierce Pharma
Thu, 04/23/15 - 04:58 pm
Tags:
AbbVie, Humira, earnings
AbbVie Profit Tops Estimates as Arthritis Drug Sales Rise
Bloomberg
Thu, 04/23/15 - 09:59 am
Tags:
AbbVie, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.